The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in ...

The global vaccine group Gavi has ordered 500,000 mpox vaccine doses from the German-Danish company Bavarian Nordic. The UN ...

Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...

On August 14, the World Health Organisation described mpox as a global health emergency by declaring it a Public Health ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

The Gavi vaccine alliance announced Wednesday a deal with Danish drugmaker Bavarian Nordic to secure 500,000 jabs against ...

With concerns that mpox may now spread more easily and be more severe, researchers warn that failing to curb the outbreak means “nobody is safe.” ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...